MACOM Technology Solutions Holdings, Inc.: Form 10-Q for the period ended Jul 4, 2025
Filed with the SEC on Aug 7, 2025 and accepted by EDGAR at Aug 7, 2025, 16:25 ET.
Management's discussion and analysis
As filed, 35,485 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended September 27, 2024 filed with the United States Securities and Exchange Commission (“SEC”) on November 12, 2024 (the “2024 Annual Report on Form 10-K”).
In this document, the words “Company,” “we,” “our,” “us,” and similar terms refer only to MACOM Technology Solutions Holdings, Inc. and its consolidated subsidiaries, and not any other person or entity.
“MACOM,” “MACOM Technology Solutions,” and related logos are trademarks of MACOM Technology Solutions Holdings, Inc. All other brands and names listed are trademarks of their respective owners.
Cautionary Note Regarding Forward-Looking Statements
This Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of this Quarterly Report on Form 10-Q contain “forward-looking statements.” In addition, we may make other written and oral communications from time to time that contain such statements. Forward-looking statements include statements regarding our business outlook, strategic plans and priorities, expectations, anticipated drivers of future revenue growth, our ability to develop new products, achieve market acceptance of those products and better address certain markets, expand our capabilities and extend our product offerings, including through the ENGIN-IC acquisition and the RF Business Acquisition, including our ability to effectively integrate the RTP Fab, risks related to any weakening of global economic conditions, including as a result of the evolving impacts from tariffs, sanctions or other trade tensions (including implementation of new tariffs or retaliatory trade measures), the impact of the July 4, 2025 Bill on our business, industry trends, our strategic investment plan, including negotiation and finalization of a definitive agreement with, and receipt of funding from the Federal and State governments, our estimated annual effective tax rate, our plans for use of our cash and cash equivalents and short-term investments, interest rate and foreign currency risks, our ability to meet working capital requirements, estimates and objectives for future operations, our future results of operations and our financial position, including liquidity, and other matters that do not relate strictly to historical facts. Forward-looking statements generally may be identified by terms such as “anticipates,” “believes,” “could,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “targets,” “will,” “would” or similar expressions or variations or the negatives of those terms. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements include, among others, the risks described in the section entitled “Risk Factors” in this Quarterly Report on Form 10-Q and the 2024 Annual Report on Form 10-K. We caution the reader to carefully consider such factors. Furthermore, such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.
Overview
We design, develop and manufacture differentiated semiconductor products and solutions for the Industrial and Defense (“I&D”), Data Center and Telecommunications (“Telecom”) industries for customers who demand high performance, quality and reliability. We are headquartered in Lowell, Massachusetts, with operational facilities throughout North America, Europe and Asia. We have more than 70 years of application expertise, combined with expertise in analog and mixed signal circuit design, compound semiconductor fabrication (including gallium arsenide (GaAs), gallium nitride (GaN), indium phosphide (InP) and specialized silicon), advanced packaging and back-end assembly and test. We offer a broad portfolio of thousands of standard and custom devices, which include integrated circuits (IC), multi-chip modules (MCM), diodes, amplifiers, switches and switch limiters, passive and active components and radio frequency (RF) and optical subsystems, which make up dozens of product lines that service over 6,000 end customers in our three primary markets. Our products are electronic components that our customers generally incorporate into larger electronic systems, such as wireless basestations, high-capacity optical networks, data center networks, radar, medical systems, satellite networks and test and measurement applications. Our primary end markets are: (1) I&D, which includes military and commercial radar, RF jammers, electronic countermeasures, communication data links, space-related electronics and various wired and wireless multi-market applications, which include industrial, medical, test and measurement and scientific applications; (2) Data Center, which includes intra-Data Center, Data Center Interconnect (DCI) applications, at 100G, 200G, 400G, 800G, 1.6T and higher speeds, enabled by our broad portfolio of analog ICs and photonic components for high speed connectivity customers; and (3) Telecom, which includes carrier infrastructure such as long-haul/metro, 5G and 6G infrastructure, satellite communications (“SATCOM”) and Fiber-to-the-X (FTTx)/passive optical network (PON), among others.
Description of Our Revenue
Revenue. Our revenue is derived from sales of high-performance RF, microwave, millimeter wave, optical and photonic semiconductor products. We design, integrate, manufacture and package differentiated, semiconductor-based products that we sell to customers through our direct sales organization, our network of independent sales representatives and our distributors.
We believe the primary drivers of our future revenue growth will include:
- continued growth in the demand for high-performance analog, digital and optical semiconductors in our three primary markets;
- introducing new products using advanced technologies, added features, higher levels of integration and improved performance;
- increasing content of our semiconductor solutions in customers’ systems through cross-selling our product lines;
- leveraging our core strength and leadership position in standard, catalog products that service all of our end applications; and
- engaging early with our lead customers to develop custom and standard products.
Our core strategy is to develop and innovate high-performance products that address our customers’ most difficult technical challenges in our primary markets: I&D, Data Center and Telecom.
We expect our revenue in the I&D market to be driven by the expanding product portfolio that we offer which services applications such as test and measurement, space-related electronics, civil and military radar, industrial, automotive, scientific and medical applications, further supported by growth in applications for our multi-market catalog products.
We expect our revenue in the Data Center market to be driven by the adoption of higher speed processing technologies and the upgrade of data center architectures to 100G, 200G, 400G, 800G and 1.6T interconnects, which we expect will drive adoption of higher speed optical and photonic components.
We expect our revenue in the Telecom market to be driven by 5G deployments, with continued upgrades and expansion of communications equipment, SATCOM networks and increasing adoption of our high-performance RF, millimeter wave, optical and photonic components.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements. The preparation of financial statements, in conformity with GAAP, requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, the reported amounts of revenue and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and could be material if our actual or expected experience were to change unexpectedly. On an ongoing basis, we re-evaluate our estimates and judgments.
We base our estimates and judgments on our historical experience and on other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making the judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates and material effects on our operating results and financial position may result. The accounting policies which our management believes involve the most significant application of judgment or involve complex estimation, are inventories and associated reserves; revenue reserves; business combinations; goodwill and intangible asset valuation; share-based compensation valuations and income taxes.
Business combinations
We apply significant estimates and judgments in order to determine the fair value of the identified tangible and intangible assets acquired, liabilities assumed and goodwill recognized in business combinations. The value of all assets and liabilities are recognized at fair value as of the acquisition date using a market participant approach. In measuring the fair value, we utilize a number of valuation techniques. When determining the fair value of property and equipment acquired, generally we must estimate the cost to replace the asset with a new asset taking into consideration such factors as age, condition and the economic useful life of the asset. When determining the fair value of intangible assets acquired, typically determined using a discounted cash flow valuation method, we use assumptions such as the timing and amount of future cash flows, discount rates, weighted average cost of capital and estimated useful lives. These assessments can be significantly affected by our judgments.
Goodwill and intangible asset valuation
Significant management judgment is required in our valuation of goodwill and intangible assets, many of which are based on the creation of forecasts of future operating results that are used in the valuation, including (i) estimation of future cash flows, (ii) estimation of the long-term rate of growth for our business, (iii) estimation of the useful life over which cash flows will occur, (iv) terminal values, if applicable, and (v) the determination of our weighted average cost of capital, which helps determine the discount rate. It is possible that these forecasts may change, and our performance projections included in our forecasts of future results may prove to be inaccurate. The value of our goodwill and purchased intangible assets could also be impacted by future adverse changes, such as a decline in the valuation of technology company stocks, including the valuation of our common stock, or a significant slowdown in the worldwide economy or in the semiconductor industry.
For additional information related to these and other accounting policies refer to Note 2 - Summary of Significant Accounting Policies to our Consolidated Financial Statements included in Item 8 of Part II, “Financial Statements and Supplementary Data,” of the 2024 Annual Report on Form 10-K and Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Income taxes
We are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves estimating our current tax exposure and assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our Consolidated Balance Sheets. We then assess the likelihood that our deferred tax assets will be recovered from future taxable income within the relevant jurisdiction. To the extent we believe that recovery is not likely, we must establish a valuation allowance. We provide valuation allowances for certain deferred tax assets where it is more likely than not that any portion will not be realized.
The application of tax laws and regulations to calculate our tax liabilities is subject to legal and factual interpretation, judgment and uncertainty in a multitude of jurisdictions. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations, including the July 4, 2025 Bill, as well as court rulings. We recognize potential liabilities for anticipated tax audit matters in the United States and other tax jurisdictions based on our estimate of whether, and the extent to which, additional taxes and interest will be due. We record an amount as an estimate of probable additional income tax liability at the largest amount that we feel is more likely than not, based upon the technical merits of the position, to be sustained upon audit by the relevant tax authority.
Results of Operations
The following table sets forth, for the periods indicated, our statements of operations data (in thousands):
| Three Months Ended July 4, 2025 | June 28, 2024 | Nine Months Ended July 4, 2025 | June 28, 2024 | |
|---|---|---|---|---|
| Revenue | $252,079 | $190,486 | $706,088 | $528,868 |
| Cost of revenue (1) | 112,643 | 89,077 | 319,387 | 244,937 |
| Gross profit | 139,436 | 101,409 | 386,701 | 283,931 |
| Operating expenses: | ||||
| Research and development (1) | 63,380 | 47,531 | 181,586 | 132,566 |
| Selling, general and administrative (1) | 38,396 | 34,162 | 115,058 | 105,233 |
| Total operating expenses | 101,776 | 81,693 | 296,644 | 237,799 |
| Income from operations | 37,660 | 19,716 | 90,057 | 46,132 |
| Other income (expense): | ||||
| Interest income | 7,598 | 5,820 | 21,837 | 16,742 |
| Interest expense | (1,178) | (1,288) | (3,723) | (3,862) |
| Loss on extinguishment of debt | — | — | (193,098) | — |
| Total other income (expense) | 6,420 | 4,532 | (174,984) | 12,880 |
| Income (loss) before income taxes | 44,080 | 24,248 | (84,927) | 59,012 |
| Income tax expense | 7,546 | 4,309 | 14,403 | 11,567 |
| Net income (loss) | $36,534 | $19,939 | $(99,330) | $47,445 |
(1) Includes (a) Amortization expense related to intangible assets arising from acquisitions and (b) Share-based compensation expense included in our condensed consolidated statements of operations as set forth below (in thousands):
| (a) Intangible amortization expense: | Three Months Ended July 4, 2025 | June 28, 2024 | Nine Months Ended July 4, 2025 | June 28, 2024 |
|---|---|---|---|---|
| Cost of revenue | $3,349 | $4,344 | $10,024 | $10,486 |
| Research and development | 2,269 | 1,340 | 6,618 | 3,426 |
| Selling, general and administrative | 1,756 | 4,337 | 6,771 | 13,257 |
| (b) Share-based compensation expense: | ||||
| Cost of revenue | $1,728 | $1,522 | $6,376 | $4,392 |
| Research and development | 7,109 | 5,446 | 25,235 | 13,173 |
| Selling, general and administrative | 8,469 | 6,377 | 29,982 | 16,527 |
25
The following table sets forth, for the periods indicated, our statements of operations data expressed as a percentage of our revenue:
| Three Months Ended July 4, 2025 | June 28, 2024 | Nine Months Ended July 4, 2025 | June 28, 2024 | |
|---|---|---|---|---|
| Revenue | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of revenue | 44.7 | 46.8 | 45.2 | 46.3 |
| Gross profit | 55.3 | 53.2 | 54.8 | 53.7 |
| Operating expenses: | ||||
| Research and development | 25.1 | 25.0 | 25.7 | 25.1 |
| Selling, general and administrative | 15.2 | 17.9 | 16.3 | 19.9 |
| Total operating expenses | 40.3 | 42.9 | 42.0 | 45.0 |
| Income from operations | 15.0 | 10.3 | 12.8 | 8.7 |
| Other income (expense): | ||||
| Interest income | 3.0 | 3.1 | 3.1 | 3.1 |
| Interest expense | (0.5) | (0.7) | (0.5) | (0.7) |
| Loss on extinguishment of debt | — | — | (27.3) | — |
| Total other income (expense) | 2.5 | 2.4 | (24.7) | 2.4 |
| Income (loss) before income taxes | 17.5 | 12.7 | (11.9) | 11.1 |
| Income tax expense | 3.0 | 2.2 | 2.0 | 2.1 |
| Net income (loss) | 14.5% | 10.5% | (13.9)% | 9.0% |
Comparison of the Three and Nine Months Ended July 4, 2025 to the Three and Nine Months Ended June 28, 2024
Revenue. Our revenue increased by $61.6 million, or 32.3%, to $252.1 million for the three months ended July 4, 2025, from $190.5 million for the three months ended June 28, 2024, and our revenue increased by $177.2 million, or 33.5%, to $706.1 million for the nine months ended July 4, 2025, from $528.9 million for the nine months ended June 28, 2024. The increase in revenue in the three and nine months ended July 4, 2025 is described by end market in the following paragraphs.
Revenue from our primary markets, the percentage of change between the periods presented, and revenue by primary markets expressed as a percentage of total revenue in the periods presented were (in thousands, except percentages):
| Three Months Ended July 4, 2025 | June 28, 2024 | % Change | Nine Months Ended July 4, 2025 | June 28, 2024 | % Change | |
|---|---|---|---|---|---|---|
| Industrial & Defense | $108,206 | $90,908 | 19.0% | $304,148 | $258,792 | 17.5% |
| Data Center | 75,822 | 49,003 | 54.7% | 213,286 | 141,662 | 50.6% |
| Telecom | 68,051 | 50,575 | 34.6% | 188,654 | 128,414 | 46.9% |
| Total | $252,079 | $190,486 | 32.3% | $706,088 | $528,868 | 33.5% |
| Industrial & Defense | 42.9% | 47.7% | 43.0% | 48.9% | ||
| Data Center | 30.1% | 25.7% | 30.2% | 26.8% | ||
| Telecom | 27.0% | 26.6% | 26.8% | 24.3% | ||
| Total | 100.0% | 100.0% | 100.0% | 100.0% |
In the three months ended July 4, 2025, our I&D market revenue increased by $17.3 million, or 19.0%, compared to the three months ended June 28, 2024. In the nine months ended July 4, 2025, our I&D market revenue increased by $45.4 million, or 17.5%, compared to the nine months ended June 28, 2024. The increase in the three months ended July 4, 2025 was primarily driven by an increase in defense program revenue and higher sales of legacy products for industrial markets. The increase in the nine months ended July 4, 2025 was primarily driven by revenue growth from defense programs, partially offset by lower sales of legacy products for industrial markets.
In the three months ended July 4, 2025, our Data Center market revenue increased by $26.8 million, or 54.7%, compared to the three months ended June 28, 2024. In the nine months ended July 4, 2025, our Data Center market revenue increased by $71.6 million, or 50.6%, compared to the nine months ended June 28, 2024. The increase in the three and nine months ended July 4, 2025 was primarily driven by an increase in sales of high-performance analog Data Center products and fees primarily supporting high speed data rates from 100G up to 1.6T.
In the three months ended July 4, 2025, our Telecom market revenue increased by $17.5 million, or 34.6%, compared to the three months ended June 28, 2024. In the nine months ended July 4, 2025, our Telecom market revenue increased by $60.2 million, or 46.9%, compared to the nine months ended June 28, 2024. The increase in the three months ended July 4, 2025 was primarily driven by an increase in sales of products for 5G and SATCOM applications. The increase in the nine months ended July 4, 2025 was primarily driven by an increase in sales of products for 5G and SATCOM applications and recent acquisitions.
Certain areas of our end markets continue to be negatively impacted by macroeconomic and geopolitical conditions, which we expect may result in weaker near-term demand for our products across all three of our primary markets. In addition, we could be negatively affected by any weakening of global economic conditions, including as a result of the evolving impacts from tariffs, sanctions or other trade tensions (including implementation of new tariffs or retaliatory trade measures).
Gross profit. Gross margin was 55.3% and 53.2% for the three months ended July 4, 2025 and June 28, 2024, respectively, and 54.8% and 53.7% for the nine months ended July 4, 2025 and June 28, 2024, respectively. Gross profit was $139.4 million and $101.4 million for the three months ended July 4, 2025 and June 28, 2024, respectively, and $386.7 million and $283.9 million for the nine months ended July 4, 2025 and June 28, 2024, respectively. Gross profit increased for the three months ended July 4, 2025 as compared to the three months ended June 28, 2024 primarily as a result of higher sales, decreases in production supplies and lower intangible asset amortization, partially offset by increases in employee-related costs. Gross profit increased for the nine months ended July 4, 2025 as compared to the nine months ended June 28, 2024 primarily as a result of higher sales and decreases in production supplies, partially offset by increases in employee-related costs and share-based compensation.
Research and development. Research and development expense increased by $15.8 million, or 33.3%, to $63.4 million, or 25.1% of our revenue, for the three months ended July 4, 2025, compared to $47.5 million, or 25.0% of our revenue, for the three months ended June 28, 2024. Research and development expense increased by $49.0 million, 37.0%, to $181.6 million, or 25.7% of our revenue, for the nine months ended July 4, 2025, compared to $132.6 million, or 25.1% of our revenue, for the nine months ended June 28, 2024. Research and development expense increased in the three and nine months ended July 4, 2025 primarily due to increases in employee-related costs, partially due to acquisitions, share-based compensation expense and development-related supply costs.
Selling, general and administrative. Selling, general and administrative expense increased by $4.2 million, or 12.4%, to $38.4 million, or 15.2% of our revenue, for the three months ended July 4, 2025, compared to $34.2 million, or 17.9% of our revenue, for the three months ended June 28, 2024. Selling, general and administrative expense increased by $9.8 million, or 9.3%, to $115.1 million, or 16.3% of our revenue, for the nine months ended July 4, 2025, compared to $105.2 million, or 19.9% of our revenue, for the nine months ended June 28, 2024. Selling, general and administrative expense increased in the three months ended July 4, 2025 primarily due to an increase in employee-related costs and share-based compensation, partially offset by lower intangible asset amortization. Selling, general and administrative expense increased in the nine months ended July 4, 2025 primarily due to an increase in employee-related costs and share-based compensation, partially offset by decreases in acquisition-related transaction costs and intangible asset amortization.
Interest income. In the three months ended July 4, 2025, interest income was $7.6 million, compared to $5.8 million for the three months ended June 28, 2024. In the nine months ended July 4, 2025, interest income was $21.8 million, compared to $16.7 million for the nine months ended June 28, 2024. The increase for the three and nine months ended July 4, 2025 is primarily due to an increase in short-term investments and associated interest income.
Loss on extinguishment of debt. In the nine months ended July 4, 2025, we recognized a $193.1 million loss on exchange of our 2026 Convertible Notes. See Note 9 - Debt to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q for additional information.
Provision for income taxes. Our income tax expense and effective income tax rates for the periods indicated were (in thousands, except percentages):
| Three Months Ended July 4, 2025 | June 28, 2024 | Nine Months Ended July 4, 2025 | June 28, 2024 | |
|---|---|---|---|---|
| Income tax expense | $7,546 | $4,309 | 14,403 | 11,567 |
| Effective income tax rate | 17.1% | 17.8% | (17.0)% | 19.6% |
27
The primary driver for the rate reduction for the three months ended July 4, 2025 as compared to the three months ended June 28, 2024 is the removal of a taxable income limitation on GILTI and foreign derived intangible income benefits. The primary driver for the rate reduction for the nine months ended July 4, 2025 as compared to the nine months ended June 28, 2024 is the non-deductibility of the loss on extinguishment of debt.
Our estimated annual effective tax rate for the fiscal year ending October 3, 2025 is expected to be approximately 15%, adjusted for discrete taxation matters arising during the interim periods, primarily the removal of the loss on extinguishment of debt of $193.1 million.
The Company is currently evaluating the impact of the July 4, 2025 Bill and does not believe there will be any significant impact to the current fiscal year ending October 3, 2025. The July 4, 2025 Bill restores the ability to deduct applicable research and development costs in the year they are incurred and no longer requires the deferral and amortization of these costs over five years, among other changes. We anticipate this change will impact the Company beginning in our fiscal year ending October 2, 2026. The July 4, 2025 Bill permits the acceleration of any unamortized balance of domestic research and development expenses which were previously deferred. In addition, the July 4, 2025 Bill increases the ITC relating to the CHIPS Act from 25% to 35% for qualifying assets placed into service after December 31, 2025.
For additional information refer to Note 14 - Income Taxes to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Liquidity and Capital Resources
The following table summarizes our cash flow activities (in thousands):
| Nine Months Ended July 4, 2025 | June 28, 2024 | |
|---|---|---|
| Cash and cash equivalents, beginning of period | $146,806 | $173,952 |
| Net cash provided by operating activities | 165,732 | 100,311 |
| Net cash used in investing activities | (246,131) | (148,615) |
| Net cash provided by (used in) financing activities | 58,796 | (8,434) |
| Foreign currency effect on cash | 263 | 90 |
| Cash and cash equivalents, end of period | $125,466 | $117,304 |
Cash Flow from Operating Activities
Our cash flow from operating activities for the nine months ended July 4, 2025 of $165.7 million consisted of a net loss of $99.3 million plus adjustments of $299.3 million, to reconcile our net loss to cash provided by operating activities, less cash used in operating assets and liabilities of $34.3 million. Adjustments to reconcile our net loss to cash provided by operating activities primarily included loss on extinguishment of debt of $193.1 million, share-based compensation expense of $61.6 million and depreciation and intangible amortization expense of $45.6 million. In addition, cash used in operating assets and liabilities was $34.3 million for the nine months ended July 4, 2025, primarily driven by an increase in accounts receivables of $22.8 million and an increase in inventories of $20.6 million, partially offset by an increase in accounts payable of $16.5 million.
Our cash flow from operating activities for the nine months ended June 28, 2024 of $100.3 million consisted of a net income of $47.4 million plus adjustments of $89.0 million, to reconcile our net income to cash provided by operating activities, less cash used in operating assets and liabilities of $36.1 million. Adjustments to reconcile our net income to cash provided by operating activities primarily included depreciation and intangible amortization expense of $49.4 million and share-based compensation expense of $34.1 million. In addition, cash used in operating assets and liabilities was $36.1 million for the nine months ended June 28, 2024, primarily driven by an increase in accounts receivables of $17.9 million, an increase in inventories of $25.1 million, a decrease of $6.1 million in accrued and other liabilities, partially offset by an increase of $14.7 million in accounts payable. The increase in inventory is primarily due to timing of certain program shipments and inventory builds to support future revenue. The increases in accounts receivable and accounts payable were primarily a result of the integration of the RF Business during the nine months ended June 28, 2024.
Cash Flow from Investing Activities
Our cash flow used in investing activities for the nine months ended July 4, 2025 of $246.1 million consisted primarily of purchases of $450.9 million of short-term investments, purchase of property under financing arrangement of $28.8 million, capital expenditures of $22.3 million, cash paid for acquisitions, net of cash acquired of $12.7 million and other investing activities of $11.0 million, offset by proceeds of $279.6 million for the sale and maturity of short-term investments.
We anticipate our capital expenditures for our fourth fiscal quarter ending October 3, 2025 to be in the range of $17.0 million to $23.0 million, which includes the purchase of approximately $12.0 million of production-related equipment to expand capacity at the RTP Fab.
Our cash flow used in investing activities for the nine months ended June 28, 2024 of $148.6 million consisted primarily of cash paid for acquisitions, net of cash acquired of $72.6 million for acquisitions, capital expenditures of $17.3 million and purchases of $330.7 million of short-term investments, offset by proceeds of $274.1 million for the sale and maturity of short-term investments. For additional information on the consideration paid for our acquisitions, see Note 3 - Acquisitions to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Cash Flow from Financing Activities
During the nine months ended July 4, 2025, our cash provided by financing activities of $58.8 million was primarily related to $86.6 million of proceeds from convertible notes, $28.8 million of proceeds from financing arrangement and $10.2 million of proceeds from stock option exercises and employee stock purchases, partially offset by $42.7 million of common stock withheld associated with employee taxes on vested equity awards and $23.2 million of fees for the convertible note exchange and payments for debt issuance costs.
During the nine months ended June 28, 2024, our cash used in financing activities of $8.4 million was primarily related to $13.9 million of common stock withheld associated with employee taxes on vested equity awards, partially offset by $6.5 million of proceeds from stock option exercises and employee stock purchases.
Liquidity
As of July 4, 2025, we held $125.5 million of cash and cash equivalents, primarily deposited with financial institutions, as well as $609.8 million of liquid short-term investments. The undistributed earnings of certain foreign subsidiaries are considered indefinitely reinvested for the periods presented and we do not intend to repatriate such earnings. We believe the decision to reinvest these earnings will not have a significant impact on our liquidity. As of July 4, 2025, cash held by our indefinitely reinvested foreign subsidiaries was $8.7 million, which, along with cash generated from foreign operations, is expected to be used in the support of international growth and working capital requirements as well as the repayment of certain intercompany loans.
On December 19, 2024, we exchanged approximately $288.8 million in aggregate principal amount of our 2026 Convertible Notes (as defined in Note 9 - Debt to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q) for approximately $257.7 million in aggregate principal amount of the 2029 Convertible Notes (as defined in Note 9 - Debt to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q), 1,582,958 newly-issued shares of the Company’s common stock, issued at a fair value of $205.9 million, and $17.6 million in cash. We also issued approximately $86.6 million in aggregate principal amount of the 2029 Convertible Notes, and net proceeds, net of amounts paid associated with the exchange, totaled approximately $63.7 million and are expected to be used for general corporate purposes. As of July 4, 2025, the aggregate principal balances of the 2026 Convertible Notes and 2029 Convertible Notes are $161.2 million and $344.3 million, respectively, and we are required to pay cash for the principal amount of the notes upon conversion.
During the fiscal quarter ended July 4, 2025, our common stock price for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending July 4, 2025 was greater than $106.76 on each applicable trading day. Therefore, holders of our 2026 Convertible Notes may convert their notes at their option at any time during the subsequent fourth fiscal quarter ended October 3, 2025 in multiples of $1,000 principal amount. For additional information on the 2026 Convertible Notes, see Note 9 - Debt to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
On January 14, 2025, we announced the execution of a preliminary, non-binding agreement with the CHIPS Program Office, which could provide for proposed direct funding from the U.S. Department of Commerce under the CHIPS Act of up to $70 million.
We plan to use our remaining available cash and cash equivalents and short-term investments for general corporate purposes, including working capital, payment on the 2026 Convertible Notes and 2029 Convertible Notes, or for the acquisition of or investment in complementary technologies, design teams, products and businesses. We believe that our cash and cash equivalents, short-term investments and cash generated from operations will be sufficient to meet our working capital requirements for at least the next twelve months. We may need to raise additional capital from time to time through the issuance and sale of equity or debt securities, and there is no assurance that we will be able to do so on favorable terms or at all.
As of July 4, 2025, we had no off-balance sheet arrangements.
For additional information related to our Liquidity and Capital Resources, see Note 9 - Debt to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Recent Accounting Pronouncements
See Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q for information about recent accounting pronouncements.
Market risk
As filed, 2,781 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and short-term investments, as well as foreign exchange rate risk.
Interest rate risk. The primary objectives of our investment activity are to preserve principal, provide liquidity and invest excess cash for an average rate of return. To minimize market risk, we maintain our portfolio in cash and diversified investments, which may consist of corporate bonds, bank deposits, money market funds, commercial paper and U.S. Treasury securities. The interest rates are variable and fluctuate with current market conditions. The risk associated with fluctuating interest rates is limited to this investment portfolio. We believe that a 1% change in interest rates would have a $7.4 million impact on our annual interest income, based on cash and cash equivalents and short-term investments balances as of July 4, 2025. We believe that a change in interest rates would not have a material impact on our results of operations, however, such change(s) could impact net income and earnings per share. We do not enter into financial instruments for trading or speculative purposes.
Foreign currency risk. To date, our international customer agreements have been denominated primarily in U.S. dollars. Accordingly, we have limited exposure to foreign currency exchange rates. The functional currency of a majority of our foreign operations continues to be in U.S. dollars with the remaining operations being local currency. Changes in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact demand in certain regions, reduce or delay customer orders, or otherwise negatively affect how customers do business with us. The effects of exchange rate fluctuations on the net assets of the majority of our operations are accounted for as transaction gains or losses. We believe that a change of 10% in such foreign currency exchange rates would not have a material impact on our financial position or results of operations.
We have entered into foreign currency exchange hedging contracts to reduce the impact of foreign currency changes on certain intercompany foreign currency denominated debt. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815, Derivatives and Hedging. These forward contracts are marked-to-market with changes in fair value recorded to earnings. As of July 4, 2025, we had $33.0 million in notional forward foreign currency contracts, which were denominated in Euro and Yen.
Controls and procedures
As filed, 1,575 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) were effective as of July 4, 2025.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Controls
Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.
Risk factors
As filed, 741 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our business involves a high degree of risk. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2024 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes in any of the risk factors described in our 2024 Annual Report on Form 10-K, except as discussed in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the fiscal quarters ended January 3, 2025 and April 4, 2025, as filed with the SEC on February 6, 2025 and on May 8, 2025, respectively.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-07-04. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-05 to 2025-07-04 | $252.1m | us-gaap:Revenues |
| Revenue | 9 months2024-09-28 to 2025-07-04 | $706.1m | us-gaap:Revenues |
| Cost of revenue | 3 months2025-04-05 to 2025-07-04 | $112.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-09-28 to 2025-07-04 | $319.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-04-05 to 2025-07-04 | $139.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-09-28 to 2025-07-04 | $386.7m | us-gaap:GrossProfit |
| Research and development | 3 months2025-04-05 to 2025-07-04 | $63.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-09-28 to 2025-07-04 | $181.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-04-05 to 2025-07-04 | $38.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-09-28 to 2025-07-04 | $115.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-04-05 to 2025-07-04 | $37.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-09-28 to 2025-07-04 | $90.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-04-05 to 2025-07-04 | $7.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-09-28 to 2025-07-04 | $14.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-05 to 2025-07-04 | $36.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-09-28 to 2025-07-04 | −$99.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-05 to 2025-07-04 | $0.48 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-09-28 to 2025-07-04 | −$1.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-05 to 2025-07-04 | $0.49 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-09-28 to 2025-07-04 | −$1.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-05 to 2025-07-04 | 75,864,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-09-28 to 2025-07-04 | 73,828,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-09-28 to 2025-07-04 | $165.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-09-28 to 2025-07-04 | $22.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2024-09-28 to 2025-07-04 | $42.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-07-04 | $125.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-07-04 | $1.13bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-07-04 | $2.00bn | us-gaap:Assets |
| Current liabilities | At period end2025-07-04 | $294.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-07-04 | $739.9m | us-gaap:Liabilities |
| Long-term debt | At period end2025-07-04 | $339.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-07-04 | $160.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-07-04 | $1.26bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493594-25-000038. Last ingested by Listed: Nov 14, 2026, 22:08 ET. Listed shows no prices and gives no investment advice.